‘Novel approach’ to treating Alzheimer’s disease discovered — it’s a gas
Alzheimer’s is the most common form of dementia — it causes memory loss, confusion, thinking problems and behavioral changes.
WAVY Norfolk on MSN1d
Alzheimer's treatment changes expected in next 10 years
Quality time takes on a whole new meaning after an Alzheimer's diagnosis. "We just finished a two-week European River cruise, ...
Mountain climbing and treating Alzheimer's: Could xenon gas have potential?
In a trial featuring a mouse model of Alzheimer's, scientists found that inhaling a mixture containing xenon gas helped ...
ConsumerAffairs1d
New study suggests ultrasound might be a promising treatment for Alzheimer’s disease
Researchers report hopeful progress in efforts to find treatments for Alzheimer’s disease. They report a recent clinical ...
FIU News1d
Promising new drug candidate for Alzheimer’s
Kyung Bo Kim discovered compounds that improved cognitive function regardless of amyloid plaque buildup — an encouraging sign ...
A Breath Away From a Cure: How Xenon Gas Could Transform Alzheimer’s Treatment
A breakthrough study highlights Xenon gas as a potential game-changer in treating Alzheimer’s disease, demonstrating its ...
Rolling Out12d
Dopamine’s surprising breakthrough in Alzheimer’s treatment
Discover how dopamine’s unexpected role in breaking down harmful plaques could revolutionize Alzheimer's treatment and ...
STAT6h
Dementia risk, higher than thought, requires a national strategy
The risk of developing dementia may be double what was previously thought. But there are things the U.S. can do to help fight ...
National Alzheimer’s Association’s 10-year vision includes big changes in treatment and detection
Quality time takes on a whole new meaning after an Alzheimer’s diagnosis. “We just finished a two-week European River cruise, ...
Dartmouth Health hopes to improve Alzheimer's care with new program
Dartmouth Health is the only health care system on the East Coast to be part of the newly launched Brain Health Navigator ...
NOLA.com5d
Alzheimer's: Mild chronic small vessel disease ups risk for dementia; Treatments vary
Mild chronic small vessel disease, or cerebral small vessel disease (CSVD), is an umbrella term for a range of conditions ...
Anavex Life Sciences Shares Rise After Positive Trial Results for Alzheimer's Treatment
Anavex Life Sciences shares were up 7% to $11.25 after the company said it saw positive trial results for its oral blarcamesine for the treatment of early Alzheimer's disease. The clinical-stage ...